Inhibitors of PI3 kinase and / or mTOR

Details for Australian Patent Application No. 2010241723 (hide)

Owner Amgen Inc.

Inventors Andrews, Kristin; Bo, Yunxin Y.; Booker, Shon; Cee, Victor J.; D'angelo, Noel; Herberich, Bradley J.; Hong, Fang-Tsao; Jackson, Claire L. M.; Lanman, Brian A.; Liao, Hongyu; Liu, Longbin; Nishimura, Nobuko; Norman, Mark H.; Pettus, Liping H.; Reed, Anthony B.; Smith, Adrian L.; Tadesse, Seifu; Tamayo, Nuria A.; Wu, Bin; Wurz, Ryan; Yang, Kevin

Agent Shelston IP

Pub. Number AU-A-2010241723

PCT Pub. Number WO2010/126895

Priority 61/258,532 05.11.09 US; 61/173,520 28.04.09 US

Filing date 27 April 2010

Wipo publication date 4 November 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/126895 Priority application(s): WO2010/126895

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241731-Systems and methods for analyzing body fluids

2010241716-Oral compositions for skin benefits